Aucubin promoted angiogenesis by regulating the VEGFR2/MEK/ERK signaling pathway. A The protein expression levels of p-ERK1/2, p-MEK1/2, p-VEGFR2, Bax and Bcl-2 in su5416-injured HUVECs after aucubin treatment (5, 10, and 20 μM) for 48 h were investigated by western blot. B–D Quantitative analysis of protein expression ratios of p-VEGFR2/VEGFR2, p-MEK1/2/MEK1/2 and p-ERK1/2/ERK1/2, respectively. Quantitative analysis of protein levels of Bcl-2 (E), Bax (F) and Bcl-2/Bax expression ratio (G) in HUVECs. (H) Cells were treated with PD98059. MEK inhibitor reversed the protective actions of aucubin on cell viability. Data are shown as mean ± SD of three independent experiments. #P < 0.05 and ##P < 0.01 vs. untreated control. *P < 0.05 and **P < 0.01 vs. su5416. $$P < 0.01 vs. su5416 + aucubin group
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Chin. Med.
Your Input Welcome
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if
additional information is required.
Oops. Something went wrong. Please try again later.